Latest News and Press Releases

Operations are Anticipated to Continually Increase, Which Includes Volume and Pricing, While it Prepares to Launch Its More Profitable Aggregate Operations  TORONTO, ON, June 11, 2018 (GLOBE...

BERKELEY HEIGHTS, N.J., Oct. 22, 2015 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) (NASDAQ:CYCCP) (Cyclacel or the Company), a biopharmaceutical company developing oral...

SARASOTA, FL--(Marketwire - April 1, 2011) - IMAP, Inc., an exclusive global merger and acquisition (M&A) organization, announced the findings of its Healthcare Industry Global Report 2011 at its...

DURHAM, N.C., Dec. 9, 2010 (GLOBE NEWSWIRE) -- Oxygen Biotherapeutics, Inc. (Nasdaq:OXBT) (SIX Swiss Exchange:OXBT), a development stage biomedical company focused on developing oxygen-rich...

REDWOOD CITY, Calif., Nov. 12, 2009 (GLOBE NEWSWIRE) -- Threshold Pharmaceuticals, Inc. (Nasdaq:THLD) today announced a presentation related to Threshold's clinical stage hypoxia-activated prodrug,...

BERKELEY HEIGHTS, N.J., Oct. 21, 2009 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) announced today that its President and Chief Executive Officer Spiro Rombotis will...

REDMOND, Wash., March 6, 2009 (GLOBE NEWSWIRE) -- ImaRx Therapeutics, Inc. (OTCBB:IMRX), a biopharmaceutical company focused on the development of new treatments for vascular disorders leveraging its...

STOCKHOLM, Sweden, Nov. 7, 2005 (PRIMEZONE) -- Interim report, January -- September 2005: -- Group sales amounted to SEK 1614 million (570 million) -- Operating profit increased to SEK 361.3...

HAWTHORNE, N.Y., Sept. 23, 2005 (PRIMEZONE) -- Taro Pharmaceutical Industries Ltd. (Nasdaq:TARO) reported today that Taro Pharmaceuticals U.S.A., Inc. has received approval from the U.S. Food and...

SAN DIEGO, Aug. 15, 2002 (PRIMEZONE) -- Scientists from McGill University and Angstrom Pharmaceuticals Inc., (San Diego, CA) published preclinical results on the combination therapy of its drug A6...